Short-term effects of periodontal therapy as an adjunct to anti-lipemic treatment

Oral Diseases

Volumn 16, Issue 7, 2010, Pages 648-654

  Fentolu, Ö ^a   Sozen T ^b   Oz S G ^b   Kale, B ^c   Sonmez Y ^c   Ozturk Tongu M ^a   Gurgan C A ^d   Ayka, Y ^d   Kirziolu, F Y ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d ANKARA UNIVERSITY   (Turkey)

Author keywords

anti lipemic treatment; hyperlipidemia; lipids; periodontal treatment

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GINGIVA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; PATIENT CARE; PERIODONTICS; PERIODONTIUM; PREVENTIVE DENTISTRY; PRIORITY JOURNAL; SHORT COURSE THERAPY; TOOTH PLAQUE;

ADULT; ANTICHOLESTEREMIC AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; DENTAL SCALING; FEMALE; FOLLOW-UP STUDIES; GINGIVAL HEMORRHAGE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; ORAL HYGIENE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PYRROLES; ROOT PLANING; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 77956837670     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01668.x     Document Type: Article

References (56)

1. Buhlin K, Gustafson A, Pockley AG, Frostegard J, Klinge B (2003). Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J 24 : 2099 2107.
2. Chait A, Han CY, Oram JF, Heinecke JW (2005). Lipoprotein-associated inflammatory proteins: markers or mediator of cardiovascular disease? J Lipid Res 46 : 389 403.
3. Chang MK, Binder CJ, Torzewski M, Witztum JL (2002). C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 99 : 13043 13048.
4. Chu X, Newman J, Park B, Nares S, Ordonez G, Iacopino AM (1999). In vitro alteration of macrophage phenotype and function by serum lipids. Cell Tissue Res 296 : 331 337.
5. Cutler CW, Shinedling EA, Nunn M et al (1999). Association between periodontitis and hyperlipidemia: cause or effect? J Periodontol 70 : 1429 1434.
6. DAiuto F, Parkar M, Andreou G, Brett PM, Ready D, Tonetti MS (2004a). Periodontitis and atherogenesis: causal association or simple coincidence? J Clin Periodontol 31 : 402 411.
7. DAiuto F, Parkar M, Andreou G et al (2004b). Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83 : 156 160.
8. DAiuto F, Ready D, Tonetti MS (2004c). Periodontal disease and C-reactive protein associated cardiovascular risk. J Periodontal Res 39 : 236 241.
9. DAiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS (2005). Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 84 : 269 273.
10. Daly CG, Mitchell DH, Highfield JE, Grossberg DE, Stewart D (2001). Bacteremia due to periodontal probing: a clinical and microbiological investigation. J Periodontol 72 : 210 214.
11. Doxey DL, Ng MC, Dill RE, Iacopino AM (1995). Platelet-derived growth factor levels in wounds of diabetic rats. Life Sci 57 : 1111 1123.
12. Ebersole JL, Cappelli D, Mott GE, Kesavalu L, Holt SC, Singer RE (1999). Systemic manifestations of periodontitis in the non-human primate. J Periodontal Res 34 : 358 362.
13. Ellis RW (1997). Infection and coronary heart disease. J Med Microbiol 46 : 535 539.
14. Endo A, Kuroda M, Tanzawa K (1976). Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett 72 : 323 326.
15. Feil PH, Grauer JS, Gadbury-Amyot CC, Kula K, McCunniff MD (2002). Intentional use of the Hawthorne effect to improve oral hygiene compliance in orthodontic patients. J Dent Educ 66 : 1129 1135.
16. Fentolu O, Oz G, Tasdelen P, Uskun E, Ayka Y, Bozkurt FY (2009). Periodontal status in subjects with hyperlipidemia. J Periodontol 80 : 267 273.
17. Grossi SG, Skrepcinski FB, DeCaro T et al (1997). Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 68 : 713 719.
18. Grover SA, Dorais M, Coupal L (2003). Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol. Epidemiology 14 : 315 320.
19. Heasman PA, Collins JG, Offenbacher S (1993). Changes in crevicler fluid levels of interleukin-1b, leukotreine B4, prostaglandin E2, tromboxane B2, and tumor necrosis factor in experimental gingivitis in humans. J Periodontal Res 28 : 241 247.
20. Iacopino AM, Cutler CW (2000). Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol 71 : 1375 1384.
21. Johansson I, Tidehag P, Lundberg V, Hallmans G (1994). Dental status, diet and cardiovascular risk factors in middle-aged people in northern Sweden. Commun Dent Oral Epidemiol 22 : 431 436.
22. Katz J, Chaushu G, Sharabi V (2001). On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol 28 : 865 868.
23. Katz J, Flugelman MY, Golberg A, Heft M (2002). Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol 73 : 494 500.
24. Kinane DF (1998). Periodontal diseases contributions to cardiovascular disease: an overview of potential mechanisms. Ann Periodontol 3 : 142 150.
25. Kiran M, Arpak MN, Unsal E, Erdoan MF (2005). The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol 32 : 266 272.
26. Koh KK, Son JW, Ahn JY et al (2002). Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease. Arterioscler Thromb Vasc Biol 22 : 19 23.
27. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P (1997). Chlamydia pneumoniae antibodies and serum lipids in Finnish men. BMJ 314 : 1456 1457.
28. Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P (1999). Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 142 : 207 210.
29. Li X, Kolltveit KM, Tronstad L, Olsen I (2000). Systemic diseases caused by oral infection. Clin Microbiol Rev 13 : 547 558.
30. Löe H, Silness J (1963). Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 21 : 533 551.
31. Lösche W, Karapetow F, Pohl A, Pohl C, Kocher T (2000). Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol 27 : 537 541.
32. Lösche W, Marshal GJ, Apatzidou DA, Krause S, Kocher T, Kinane DF (2005). Lipoprotein associated phospholipase A2 and plasma lipids in patients with destructive periodontal disease. J Clin Periodontol 32 : 640 644.
33. Maglakelidze N, Galogre A, Tsagareli Z (2005). Functional-morphologic aspects of changes of mucosal gingiva microcirculatory bed vessels in experimental gingivitis against the background of hypercholesterolemia. Georgian Med News 4 : 71 74.
34. Moeintaghavi A, Haerian-Ardakani A, Talebi-Ardakani M, Tabatabaie I (2005). Hyperlipidemia in patients with periodontitis. J Contemp Dent Pract 6 : 78 85.
35. Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C (2004). Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. J Clin Periodontol 31 : 25 29.
36. Morita M, Horiuchi M, Kinoshita Y, Yamamato T, Watanabe T (2004). Relationship between blood triglyceride levels and periodontal status. Commun Dent Health 21 : 32 36.
37. Murray CJ, Lopez AD (1997). Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349 : 1436 1442.
38. Nagashima H, Aoka Y, Sakomura Y et al (2002). A 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg 36 : 158 163.
39. Noack B, Jachmann I, Roscher S et al (2000). Metabolic diseases and their possible link to risk indicators of periodontitis. J Periodontol 71 : 898 903.
40. Offenbacher S, Jared HI, OReilly PG et al (1998). Potential pathogenic mechanisms of periodontitis associated pregnancy complications. Ann Periodontol 3 : 233 250.
41. Oz SG, Fentoglu O, Kilicarslan A et al (2007). Beneficial effects of periodontal treatment on metabolic control of hypercholesterolemia. South Med J 100 : 686 691.
42. Pohl A, Krause S, Brachmann C, Pohl P, Gangler W, Losche W (1992). Blood cholesterol-a risk factor for progressive marginal periodontitis? J Dent Res 71 : 654.
43. Pussinen PJ, Vilkuna-Rautiainen T, Alfthan G et al (2004). Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide. Arterioscler Thromb Vasc Biol 24 : 2174 2180.
44. Rodrigues DC, Taba MJ, Novaes AB, Souza SL, Grisi MF (2003). Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol 74 : 1361 1367.
45. Ross R (1999). Atherosclerosis-an inflammatory disease. N Engl J Med 340 : 115 126.
46. Saito T, Shimazaki Y, Sakamoto M (1998). Obesity and periodontitis. N Engl J Med 339 : 482 483.
47. Sever PS, Dahlöf B, Poulter NR et al (2003). Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361 : 1149 1158. (Pubitemid 36398384)
48. Shepherd J, Cobbe SM, Ford I et al (1995). Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333 : 1301 1307.
49. Silness J, Löe H (1964). Periodontal disease in pregnancy. II Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 22 : 121 135.
50. Skaleric U, Schara R, Medvescek M, Hanlon A, Doherty F, Lessem J (2004). Periodontal treatment by Arestin and its effects on glycemic control in type 1 diabetes patients. J Int Acad Periodontol 6 : 160 165.
51. Stashenko P, Obernesser MS, Prostak L, Haffajee AD, Socransky SS (1991). Levels of interleukin 1 beta in tissue sites of active periodontal disease. J Clin Periodontol 18 : 548 554.
52. Sukhova GK, Williams JK, Libby P (2002). Statins reduce inflammation in atheroma of non human primates independent of effects on serum cholesterol. Arterioscler Thromb Vasc Biol 22 : 1452 1458.
53. Uchiumi D, Kobayashi M, Tachikawa T, Hasegawa K (2004). Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats. J Periodontal Res 39 : 120 128.
54. Volanakis JE (2001). Human C-reactive protein: expression, structure, and function. Mol Immunol 38 : 189 197.
55. Wakai K, Kawamura T, Umemura O et al (1999). Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol 26 : 664 672.
56. Wong B, Lumma WC, Smith AM, Sisko JT, Wright SD, Cai TQ (2001). Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation. J Leukoc Biol 69 : 959 962.